葵花药业: 第五届董事会第七次会议决议公告

Group 1 - The board meeting of Kew Flower Pharmaceutical Group Co., Ltd. was held on May 16, 2025, via telecommunication, with all 9 directors participating in the vote [1][2] - The board approved the appointment of Mr. Xiao Lin as the deputy general manager, effective from the date of the board's approval until the current board's term ends [1][2] - The remuneration for the newly appointed executive will be in accordance with the company's senior management remuneration management system and relevant performance assessment rules [1] Group 2 - The voting results for the board meeting were unanimous, with 9 votes in favor, 0 against, and 0 abstentions [2] - Prior to the board's review, the proposal was approved by the company's nomination committee and the remuneration and assessment committee [2] - Relevant documents will be disclosed in designated media such as Securities Daily, Shanghai Securities Journal, and the website of CNINFO [1]